Fewer Side Effects With Naproxen vs Low-Dose Colchicine in Gout Flare Treatment – Renal and Urology News
Researchers compared the effectiveness and safety of naproxen with low-dose colchicine in the treatment of gout flares in primary care.
Related Articles
GLP-1RAs Linked With Reduced Risks of Major Outcomes in Real-World Advanced CKD, Dialysis
Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse…
Focal Therapy Finding Its Niche for Intermediate-Risk Prostate Cancer
Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).
ARO-C3 Shows Early Promise for Reducing Complement Activation in IgA Nephropathy – Renal and Urology News
ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.
Dialysis Industry Consolidated, Increased Commercial Prices After 2005
Investigators studied recent trends in chain ownership, physician ownership, and medical directorship of dialysis facilities in the US.
KDIGO Discusses the Need for CKD Prevention, the Complexity of Maintaining Kidney Health
Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.
Rituximab Linked With Renal Response in Refractory Lupus Nephritis
Rituximab may offer therapeutic value in lupus nephritis unresponsive to standard regimens.
Clinical Quiz: A Young Woman With Acute Kidney Injury, Lupus Nephritis – Renal and Urology News
Left: Light microscopy | Right: Immunofluorescence microscopy A 24-year-old Hispanic female who is previously healthy presented to the hospital with
Lower-Dose Abiraterone Is as Efficacious as the Standard Dose for mCRPC – Renal and Urology News
Standard-dose abiraterone for mCRPC is costly, more toxic, and requires fasting, so a trial tested whether a lower dosage would suffice.
Monogenic Lupus Nephritis Signals Earlier Onset and Worse Renal Outcomes – Renal and Urology News
A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease.
Renal Hyperfiltration Trajectory Tied With Risk of ESKD, Cardiovascular Events, and Death – Renal and Urology News
Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.